Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window?
Lorena Incorvaia, Alessandro Perez, Cláudia Marchetti, et al.
Cancer Treatment Reviews (2023) Vol. 121, pp. 102650-102650
Open Access | Times Cited: 16

Showing 16 citing articles:

Progesterone Enhances Niraparib Efficacy in Ovarian Cancer by Promoting Palmitoleic-Acid-Mediated Ferroptosis
Nayiyuan Wu, Xiu Zhang, Chao Fang, et al.
Research (2024) Vol. 7
Open Access | Times Cited: 11
Genomic Features of Homologous Recombination Deficiency in Breast Cancer: Impact on Testing and Immunotherapy
Umer Ali, Sunitha Vungarala, Venkataswarup Tiriveedhi
Genes (2024) Vol. 15, Iss. 2, pp. 162-162
Open Access | Times Cited: 5
Deciphering the mechanisms of PARP inhibitor resistance in prostate cancer: Implications for precision medicine
Cheng Wang, Xiaoran Han, Shaoqiu Kong, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 185, pp. 117955-117955
Closed Access
Clinical-genomic characteristics of homologous recombination deficiency (HRD) in breast cancer: application model for practice
Juan Du, Lizhe Zhu, Chaorui Duan, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
Polθ: emerging synthetic lethal partner in homologous recombination-deficient tumors
Tancredi Didier Bazan Russo, Clarissa Mujacic, Emilia Di Giovanni, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 11, pp. 1619-1631
Open Access | Times Cited: 3
BRCA functional domains associated with high risk of multiple primary tumors and domain-related sensitivity to olaparib: the Prometheus Study
Lorena Incorvaia, Cláudia Marchetti, Chiara Brando, et al.
ESMO Open (2025) Vol. 10, Iss. 2, pp. 104076-104076
Closed Access
Precision Medicine in High-Grade Serous Ovarian Cancer: Targeted Therapies and the Challenge of Chemoresistance
Sara Polajžer, Katarina Černe
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2545-2545
Open Access
Homologous Recombination Deficiency Among Patients with Germline or Somatic non-BRCA1/2 Homologous Recombination Repair Gene Variations
Yue Li, Xinhua Yang, Haoyang Cai, et al.
Research Square (Research Square) (2025)
Closed Access
The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumors
Lorena Incorvaia, Tancredi Didier Bazan Russo, Valerio Gristina, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 2
The hallmarks of tissue-agnostic therapies and strategies for early anticancer drug discovery
Jihyeob Mun, Byungho Lim
Drug Discovery Today (2024) Vol. 29, Iss. 12, pp. 104203-104203
Open Access | Times Cited: 2
Anthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD)
Lorena Incorvaia, G. Badalamenti, Giuseppina Novo, et al.
ESMO Open (2023) Vol. 9, Iss. 1, pp. 102196-102196
Open Access | Times Cited: 4
How Banf1 Functions to Inhibit the Activity of PARP1
Bond Bai
(2024)
Closed Access
Novel PET tracers in breast cancer for treatment optimization: clinical utility and future perspectives
Laura Gilardi, Lighea Simona Airò Farulla, Elena Bonatto, et al.
Current Opinion in Oncology (2024) Vol. 36, Iss. 6, pp. 514-520
Closed Access
Somatic and germline aberrations in homologous recombination repair genes among Chinese high-risk breast cancer patients by multi-gene next-generation sequencing
Ling Ling Xie, Jie Chen, YanYing Zheng, et al.
Clinical & Translational Oncology (2024)
Closed Access
Pancreatic Neuroendocrine Tumor: The Case Report of a Patient with Germline FANCD2 Mutation and Tumor Analysis Using Single-Cell RNA Sequencing
Ekaterina Avsievich, Diana Salimgereeva, Alesia Maluchenko, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 24, pp. 7621-7621
Open Access
Homologous recombination deficiency (HRD) diagnostics: underlying mechanisms and new perspectives
Andrey Kechin, Maksim Koryukov, Regina Mikheeva, et al.
Cancer and Metastasis Reviews (2024) Vol. 44, Iss. 1
Closed Access
Page 1

Scroll to top